About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSoutheastern U.S.
Team (8)
Ezra
R
Ezra
R.
Lowe, Ph.D.
Galectin Therapeutics
team_member
Jack
W
Jack
W.
Callicutt,
CPA
Galectin Therapeutics
team_member
Jeff
Katstra
Jeff
Katstra
Galectin Therapeutics
team_member
Jessica
Kopaczewski
Jessica
Kopaczewski
Galectin Therapeutics
team_member
Joel
Lewis
Joel
Lewis
Galectin Therapeutics
team_member
Khurram
Jamil
Khurram
Jamil, M.D.
Galectin Therapeutics
team_member
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
10
As Collaborator
2
Total Enrollment
727
By Phase
PHASE2/PHASE3: 1PHASE1: 5PHASE2: 6
By Status
COMPLETED: 8WITHDRAWN: 2ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04365868Lead Sponsor
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
PHASE2/PHASE3Active, not recruiting
357 participants
Started: Jun 22, 2020 · Completed: Sep 30, 2025
NCT04332432Lead Sponsor
A Single-dose, Open-label, Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment
PHASE1Completed
38 participants
Started: Jun 16, 2020 · Completed: Mar 9, 2022
NCT02575404Collaborator
GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients
PHASE1Completed
36 participants
Started: May 16, 2016 · Completed: Oct 10, 2022
NCT02407041Lead Sponsor
An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis
PHASE2Completed
5 participants
Started: Sep 30, 2015 · Completed: Mar 31, 2018
NCT02421094Lead Sponsor
Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis
PHASE2Completed
30 participants
Started: Sep 30, 2015 · Completed: Sep 27, 2016
Locations (1)
Headquarters
Norcross, GA, United States
Map
Loading map...